AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in AN2 Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- +3 vs. Q4 2023
- Shares held
- 18.7M
- −1.66M (−8.1%) vs. Q4 2023
- Total value
- $60.9M
- −$357.0M (−85.4%) vs. Q4 2023
- New holders
- 18
- 13 more added
- Sold out
- 15
- 16 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 5,551,295 | $18.0M | 0.23% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,556,554 | $5.06M | 0.00% | −2880.0% | Reduced |
| TCG Crossover Management, LLC | 1,555,118 | $5.05M | 0.40% | −1,123,091−41.9% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,388,889 | $4.51M | 0.19% | 00.0% | Unchanged |
| BVF Inc | 1,239,470 | $4.03M | 0.11% | −324,493−20.7% | Reduced |
| Janus Henderson Group PLC | 1,221,145 | $3.98M | 0.00% | −58,830−4.6% | Reduced |
| Avidity Partners Management LP | 1,150,000 | $3.74M | 0.13% | +10,000+0.9% | Added |
| Octagon Capital Advisors LP | 1,103,000 | $3.58M | 0.44% | +438,425+66.0% | Added |
| Vanguard Group Inc | 1,047,769 | $3.41M | 0.00% | −4,822−0.5% | Reduced |
| Adage Capital Partners GP, L.L.C. | 312,615 | $1.02M | 0.00% | −588,057−65.3% | Reduced |
| BlackRock Inc. | 291,086 | $946.0K | 0.00% | −14,755−4.8% | Reduced |
| Ghost Tree Capital, LLC | 219,331 | $712.8K | 0.23% | +219,331 | New |
| Susquehanna International Group, LLP | 202,850 | $659.3K | 0.00% | +103,446+104.1% | Added |
| Geode Capital Management, LLC | 179,370 | $583.1K | 0.00% | +747+0.4% | Added |
| Acadian Asset Management LLC | 163,496 | $529.0K | 0.00% | +163,496 | New |
| Walleye Capital LLC | 132,787 | $431.6K | 0.00% | +132,787 | New |
| Alyeska Investment Group, L.P. | 100,000 | $325.0K | 0.00% | +50,000+100.0% | Added |
| Nantahala Capital Management, LLC | 98,278 | $319.4K | 0.03% | −150,000−60.4% | Reduced |
| Millennium Management LLC | 96,914 | $315.0K | 0.00% | +57,240+144.3% | Added |
| Two Sigma Investments, LP | 94,168 | $306.0K | 0.00% | +74,920+389.2% | Added |
| Marshall Wace, LLP | 82,498 | $268.1K | 0.00% | −254,823−75.5% | Reduced |
| UBS Asset Management Americas Inc | 76,200 | $247.7K | 0.00% | +76,200 | New |
| Citigroup Inc | 70,807 | $230.1K | 0.00% | −89,679−55.9% | Reduced |
| State Street Corp | 60,302 | $196.0K | 0.00% | +22,000+57.4% | Added |
| Jane Street Group, LLC | 59,166 | $192.3K | 0.00% | −279−0.5% | Reduced |
| Qube Research & Technologies Ltd | 50,365 | $163.7K | 0.00% | −21,843−30.3% | Reduced |
| Squarepoint Ops LLC | 49,607 | $161.2K | 0.00% | +49,607 | New |
| RMB Capital Management, LLC | 45,942 | $149.3K | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 43,814 | $142.4K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 40,300 | $131.0K | 0.01% | +40,300 | New |
| XTX Topco Ltd | 38,666 | $125.7K | 0.02% | +38,666 | New |
| Dimensional Fund Advisors LP | 38,115 | $123.9K | 0.00% | +38,115 | New |
| Occudo Quantitative Strategies LP | 37,697 | $122.5K | 0.02% | +37,697 | New |
| Northern Trust Corp | 36,363 | $118.2K | 0.00% | +3,313+10.0% | Added |
| Captrust Financial Advisors | 28,667 | $93.2K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 28,370 | $92.2K | 0.00% | +14,324+102.0% | Added |
| Barclays PLC | 28,318 | $92.0K | 0.00% | −15,920−36.0% | Reduced |
| Credit Suisse AG | 26,630 | $86.5K | 0.00% | +26,630 | New |
| Bridgeway Capital Management, LLC | 26,292 | $85.4K | 0.00% | −10,700−28.9% | Reduced |
| HRT Financial LP | 24,366 | $79.0K | 0.00% | +24,366 | New |
| Private Advisor Group, LLC | 22,500 | $73.1K | 0.00% | +22,500 | New |
| Swiss National Bank | 20,575 | $66.9K | 0.00% | +20,575 | New |
| UBS Group AG | 19,574 | $63.6K | 0.00% | +19,574 | New |
| Chicago Partners Investment Group LLC | 22,001 | $52.1K | 0.00% | +22,001 | New |
| Bank of America Corp | 14,972 | $48.7K | 0.00% | −6,922−31.6% | Reduced |
| Atom Investors LP | 11,905 | $38.7K | 0.00% | +11,905 | New |
| Clear Street Markets LLC | 10,000 | $33.0K | 0.02% | +10,000 | New |
| California State Teachers Retirement System | 9,251 | $30.1K | 0.00% | +9,251 | New |
| Morgan Stanley | 4,164 | $13.5K | 0.00% | +833+25.0% | Added |
| Tower Research Capital LLC (TRC) | 1,113 | $3.62K | 0.00% | +1,050+1,666.7% | Added |
| Advisor Group Holdings, Inc. | 300 | $975 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 250 | $812 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 211 | $686 | 0.00% | −47−18.2% | Reduced |
| Wells Fargo & Company | 128 | $416 | 0.00% | +2+1.6% | Added |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −187,399−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −157,891−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −132,000−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −51,660−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −39,472−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −33,997−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −25,842−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −25,800−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −19,285−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −18,337−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −16,483−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −13,392−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −9,842−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −670−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −621−100.0% | Sold out |